Clisma fosfato sodico acido - rectal solution 120 ml

Product Description

Rectal solution.

Indications

Sodium Phosphate Enema is useful in the treatment of constipation, clinical conditions that require pre- and post-operative intestinal emptying, in preparation for radiological examinations and endoscopic investigations of the upper intestinal tract.

Composition

Active ingredients: 100 ml of solution contain: active ingredients: sodium phosphate monobasic dihydrate 18.08 g equal to sodium phosphate monobasic monohydrate 16 g, sodium phosphate dibasic dodecahydrate 8.03 g, equal to sodium phosphate dibasic heptahydrate 6 g. Excipients with known effect: Methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216). For the full list of excipients, see section 6.1.

Excipients: Methyl parahydroxybenzoate, propyl parahydroxybenzoate, purified water.

Directions for use and Dosage

Adults and adolescents (12–18 years): 1 120 ml bottle. Do not use more than one bottle per day. Each bottle should be used for a single administration; any residual medicinal product should be discarded. Administration can be carried out at room temperature. If lukewarm water is preferred, simply place the bottle in contact with hot water (by immersion or under the tap). For best results, it is advisable to administer the product lying on the left side. For a greater cleansing action, assume the knee-chest position for a few minutes immediately after administration.

Instructions for use:

1. Unscrew the bottle's seal, remove the cannula from the package, and screw it completely onto the neck of the bottle.
2. Hold the bottle, lubricate the cannula with a few drops of solution, and gently insert the cannula into the rectum. Then squeeze the bottle thoroughly until the solution comes out completely. Some solution residue is expected to remain in the bottle.
3. Once administration is complete, remove the cannula while holding the bottle down. Discard the product, after placing the empty bottle in its box, according to the regulations for the disposal of medicinal products.
4. Remain lying down for a few minutes, possibly on your stomach, before sitting up. Go to the bathroom as soon as you feel the urge to evacuate, which usually occurs within 5 minutes. In any case, it is not necessary to retain the solution for more than 10–15 minutes.

Warnings

The 120 ml bottle should not be used in children under 12 years of age. Laxative abuse (frequent or prolonged use or excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium), and other essential nutrients. In more severe cases, dehydration or hypokalemia may occur, which can lead to cardiac or neuromuscular dysfunction, especially in the case of concomitant treatment with cardiac glycosides, diuretics, or corticosteroids. Patients should be encouraged to drink fluids to help prevent dehydration, particularly those with conditions that may predispose them to dehydration, or those taking medications that may decrease glomerular filtration rate, such as diuretics, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (ARBs), or nonsteroidal anti-inflammatory drugs (NSAIDs). Since Sodium Phosphate Sella contains sodium phosphates, there is a risk of elevated serum sodium and phosphate levels and decreased calcium and potassium levels, and consequently hypernatremia, hyperphosphatemia, hypocalcemia, and hypokalemia, which may occur with clinical signs such as tetany and renal failure. Laxative abuse can cause dependence (and, therefore, the possible need to progressively increase the dosage), chronic constipation, and loss of normal bowel function (intestinal atony). Repeated use of laxatives may cause a decrease in bowel function. This can lead to habituation or other types of damage. Prolonged use of a laxative to treat constipation is not recommended. Pharmacological treatment of constipation should be considered an adjunct to hygienic and dietary measures (e.g., increased plant fiber and fluid intake, physical activity, and intestinal motility retraining). Treatment of chronic or recurrent constipation always requires medical intervention for diagnosis, medication prescription, and monitoring during therapy. Careful medical evaluation is essential when the need for a laxative arises from a sudden change in previous bowel habits (frequency and characteristics of bowel movements) that lasts more than two weeks, or when laxative use fails to produce effects. Elderly or unhealthy individuals, and patients with uncontrolled hypertension, ascites, heart disease, or changes in the rectal mucosa (ulcers, fissures), should consult their doctor before using the medicine. Patients should be advised to discontinue administration if resistance is encountered, as forceful administration of the enema may cause injury. In cases of constipation, it is recommended first to correct eating habits by supplementing the daily diet with adequate fiber and water. When using laxatives, it is advisable to drink at least 6–8 glasses of water or other liquids per day to help soften the stool. Important information about some excipients: Sella Sodium Phosphate contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216), which may cause allergic reactions (possibly delayed).

Format

120 ml.